The purpose of this study is to compare the safety and IOP-lowering efficacy of various low
dose travoprost formulations in patients with open-angle glaucoma or ocular hypertension.
- Patients 18 years of age or older, either sex or race with open-angle glaucoma or
confirmed ocular hypertension
- Other protocol-defined inclusion criteria may apply
- Age related
- Other protocol-defined exclusion criteria may apply